Answers are grounded in this paper and cite their sources.
Genome-wide plasma cfDNA pan-cancer screening of 1002 healthy elderly identified 15 individuals with CNAs of unknown origin. Nine participants were reassessed over 3-5 years through health questionnaires, WB-MRI, and cfDNA and blood analyses. CNAs resolved in two cases but persisted in seven mainly associated with low-grade clonal mosaicism. These findings suggest cfDNA CNAs may be transient or serve as early markers of clonal mosaicism, preceding clinical detection by years.
No takes yet. Share an insight, caveat, or question.
Tuveri et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: